Navigation Links
Study Offers Support for Surgery After Compression Fracture
Date:8/10/2010

By Steven Reinberg
HealthDay Reporter

TUESDAY, Aug. 10 (HealthDay News) -- After studies last year found that a type of surgery called vertebroplasty was no better than a sham procedure in treating painful compression fractures, a new study now suggests the therapy can, in fact, ease some patients' pain.

In this (typically) outpatient procedure, doctors inject a type of stabilizing cement into the affected part of the spine.

For some people with weak bones who fracture the small bones in their spine -- an injury called an acute osteoporotic vertebral compression fracture -- vertebroplasty can be a safe and effective treatment, Dutch researchers conclude in the Aug. 10 online edition of The Lancet.

The study was funded in part by Cook Medical, which makes material used in vertebroplasty.

"Pain relief after the procedure is immediate, sustained for one year, and is significantly better than that achieved with conservative treatment and at acceptable costs," wrote a team led by Dr. Caroline Klazen, from St. Elisabeth Ziekenhuis in Tilburg, the Netherlands.

But other experts cast doubt on the findings, noting that for most of the study participants, pain resolved on its own without the need for surgery.

The new Dutch study involved 431 patients, aged 50 or older, with osteoporotic vertebral compression fractures. The patients had been in pain for six weeks or less. The researchers randomly assigned them to receive vertebroplasty or conservative treatment.

Conservative treatment included taking pain relievers, ice and heat treatments, and later a stretching and back strengthen program. In addition, a back brace may be called for, experts say.

However, the researchers noted that more than half (53 percent) of participants had their pain spontaneously disappear during the assessment phase of the study.

Among the 202 remaining patients, the 101 treated with vertebroplasty ha
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. More Medicaid Patients Using ERs, Study Finds
2. Study shows physicians reluctant to use chemoprevention for prostate cancer
3. Many Stroke Patients Stop Taking Meds, Study Shows
4. UC Denver study finds beautiful women face discrimination in certain jobs
5. Surgery better than radiation, hormone treatments for some prostate cancer, study shows
6. Tattooing linked to higher risk of hepatitis C: UBC study
7. Women Can Safely Get Pregnant Right After Miscarriage, Study Shows
8. Type 2 Diabetes Might Harm Young Brain, Study Suggests
9. Study shows splitting bowel preparation dosage is most effective cleansing method before colonoscopy
10. Epilepsy Drugs Dont Raise Suicide Risk, Study Shows
11. Study finds proximity could be key to success of healing prayer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Offers Support for Surgery After Compression Fracture
(Date:7/23/2014)... shown that some high-profile athletes who suffered repeated blows ... clumps in their brains. Those clumps suggest the athletes ... scientists are working on tests that might be able ... an article in Chemical & Engineering News (C&EN) ... Society. , In the article, Lauren Wolf, a senior ...
(Date:7/23/2014)... together for the first time to call for better ... worldwide suffering from the condition. , Psoriatic arthritis (PsA) ... damage if left untreated. , PsA tends to affect ... red, scaly rash, and affects approximately two per cent ... in five go on to develop PsA usually ...
(Date:7/23/2014)... Louis (PRWEB) July 23, 2014 Five years ... its doors there were few options for babies diagnosed with ... delivery, or travel across the country for innovative fetal therapies. ... Fetal Care Institute to care for their babies in the ... surgeries and interventions. , “A number of the babies ...
(Date:7/23/2014)... models of human oral cancer treated with an agent ... surrounding tissues, researchers from the School of Dentistry and ... Science Center at San Antonio found. The Health Science ... study, which is described in the journal Oral ... , Oral squamous cell carcinoma is the eighth most ...
(Date:7/23/2014)... July 23, 2014 SpaRoom® ... SpaRoom’s top product and premier diffuser, is now available ... and an improved motor for maximum quality. The new ... now available on SpaRoom.com for $60 along with the ... ultrasonic pulsations to create a long-lasting, tranquil mist. Add ...
Breaking Medicine News(10 mins):Health News:Psoriatic arthritis patients need better screening, warns panel of experts 2Health News:St. Louis Fetal Care Institute Marks Five Years of Life Changing Care and Fetal Surgery 2Health News:Anti-pain agent shrinks oral cancers, leaves healthy tissues alone 2Health News:SpaRoom® Unveils New Sleek Color, Improved AromaMist™ 2
... to The Diabetes Research Institute of Miami on ... behalf of the motorcycle franchisee, ... check to The Diabetes Research Institute of Miami in honor ... the,leading voluntary insurer announced the motorcycle franchisee as its,100,000th Online ...
... epilepsy and depression, researchers say , , FRIDAY, ... deep brain stimulation sensor that can monitor levels ... Clinic researchers and colleagues. , The wireless instantaneous ... the brain to provide real-time measurement of chemicals ...
... Local Patients May Be at,Risk, PHILADELPHIA, Sept. 12 ... blood supply alert for New Jersey and,southeastern Pennsylvania., ... critical need for Type O,blood. Brigid O,Neill-LaGier, Chief Executive ... the community to donate blood. "The blood,supply is a ...
... reports a hiring trend over the past four months within High-Tech ... is has become a “recruiters” market causing both parties to change ... ... 2008 -- Lucas Group, an executive search firm, today reports a ...
... yearn to wear the sheer, body-hugging fashions available today, we ... dreaded back fat rolls and lumps. A study published in ... the official medical journal of the American Society of Plastic ... these unsightly bumps and bulges while hiding the scar under ...
... ATSI ), manufacturer and marketer of state-of-the-art ... unprecedented number,of scientific presentations and symposia will focus ... for Cardio-Thoracic Surgeons (EACTS),meeting. The EACTS is a ... and is being held in Lisbon, Portugal from ...
Cached Medicine News:Health News:Aflac Celebrates With Peterson's Harley Davidson of Miami as 100,000th Online Billing Customer 2Health News:American Red Cross Issues Local Blood Supply Alert 2Health News:American Red Cross Issues Local Blood Supply Alert 3Health News:Lucas Group Reports Hiring Trend in High-Tech Medical Device 2Health News:Say 'goodbye' to back fat rolls 2Health News:ATS Medical Products Featured Prominently in Scientific Presentations at European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting 2Health News:ATS Medical Products Featured Prominently in Scientific Presentations at European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting 3Health News:ATS Medical Products Featured Prominently in Scientific Presentations at European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting 4
(Date:7/23/2014)... 2014 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) ... and research facility: Ampio Pharmaceuticals, 373 Inverness ... (720) 437-6500 Michael Macaluso , Ampio,s ... facility will be fully operational this summer, right ... Ampion TM necessary to accommodate the company,s BLA ...
(Date:7/23/2014)... 23, 2014  ArmaGen, a privately held biotechnology ... severe neurological disorders, announced today that it has ... with Shire plc to develop AGT-182, an investigational ... both the central nervous system (CNS) and somatic ... MPS II, Hunter syndrome is a rare, severe, ...
(Date:7/22/2014)... TOKYO , July 23, 2014   ... Taiho Pharmaceutical Co., Ltd. (hereinafter "Taiho"), a ... the company will be investing US$30 million in Remiges ... venture capital fund. Taiho has a long ... needs of oncologists and cancer patients. Our development of ...
Breaking Medicine Technology:Ampio Pharmaceuticals announces the opening of its new headquarters, manufacturing and research facility in Englewood Colorado 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 3Taiho Pharmaceutical Invests US$30 Million in Remiges BioPharma Fund, LP 2
... Abbott (NYSE: ABT ) scientists and independent researchers ... Abbott,s investigational oncology compounds at this year,s American Society ... June 4-8 in Chicago . The presentations include ... and a humanized monoclonal antibody directed against CS1. Abbott,s oncology ...
... EAST HANOVER, N.J. , June 3 ... study of Afinitor® (everolimus) tablets plus best supportive care met ... or time without tumor growth, in patients with advanced pancreatic ... I n A dvanced N euroendocrine T ...
Cached Medicine Technology:Abbott to Present Data on Several Investigational Cancer Treatments at American Society of Clinical Oncology Annual Meeting 2Abbott to Present Data on Several Investigational Cancer Treatments at American Society of Clinical Oncology Annual Meeting 3Abbott to Present Data on Several Investigational Cancer Treatments at American Society of Clinical Oncology Annual Meeting 4Abbott to Present Data on Several Investigational Cancer Treatments at American Society of Clinical Oncology Annual Meeting 5Abbott to Present Data on Several Investigational Cancer Treatments at American Society of Clinical Oncology Annual Meeting 6Abbott to Present Data on Several Investigational Cancer Treatments at American Society of Clinical Oncology Annual Meeting 7Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 2Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 3Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 4Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 5Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 6Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 7
... Forma 1400 Series ... specifically to revolutionize working ... cabinet. The most comfortable, ... Class II cabinet on ...
... The Premier 12 Holter Analysis Kit incorporates ... Dispersion with other powerful DMS Holter analysis ... TWA analysis possible in less than 10 ... TWA, for visual verification and validation. The ...
... Designed for ease of use and patient ... smooth edges for comfort and is available ... to a perfect fit. For hard to ... trach collar to your specifications. Don't just ...
... more comfortable, and you will too., ... and to avoid the knotty problems associated ... ties, consider the Dale® Tracheostomy Tube Holder. ... narrow fastener tabs of the Dale® Tracheostomy ...
Medicine Products: